Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2011
06/08/2011EP1817312B1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
06/08/2011EP1809628B1 Phenylurea derivatives used as inhibitors of tyrosinkinase for treating tumors
06/08/2011EP1479397B1 2,4,6-triamino-1,3,5-triazine derivative
06/08/2011EP1434579B1 Imidazole derivatives as antiinflammatory agents
06/08/2011CN1926097B Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors
06/08/2011CN102089307A Pyrrolopyridines as kinase inhibitors
06/08/2011CN102089306A Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
06/08/2011CN102089305A Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [3, 2, 1-iJ] quinoline compounds
06/08/2011CN102089302A Nitrogenated bicyclic heterocyclic compound
06/08/2011CN102089279A Biaryl PDE4 inhibitors for treating inflammation
06/08/2011CN102086468A Compound for preventing and treating human papillomavirus infectious diseases and screening method thereof
06/08/2011CN102086211A Aromatic heterocyclic compounds serving as protein kinase inhibitor
06/08/2011CN102086198A Method for preparing 1,2-dihydroisoquinoline compounds of pyrazole ring
06/08/2011CN101659663B Indolizine derivative as well as preparation method and application thereof
06/08/2011CN101510590B Organic electroluminescent element and display
06/08/2011CN101305003B (1-aza-bicyclo[3.3.1] n0n-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-ACHR for the treatment of psychotic and neurodegenerative disorders
06/08/2011CN101058576B Rhizoma corydalis decumbentis extract, preparation method thereof, medicament composition containing the rhizoma corydalis decumbentis and application thereof
06/07/2011US7956072 Agent for repairing corneal sensitivity containing amide compound
06/07/2011US7956071 Imidazole compounds
06/07/2011US7956066 Imidazole compounds
06/07/2011US7956064 Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
06/07/2011US7956060 Pyrimidine derivative compound
06/07/2011US7956057 Imidazole compounds
06/07/2011CA2555824C Fused-ring 4-oxopyrimidine derivative
06/07/2011CA2482004C Compounds having unique cb1 receptor binding selectivity and methods for their production and use
06/07/2011CA2444634C Spiropyrazole compounds
06/03/2011WO2011066183A1 Novel spiropiperidine compounds
06/03/2011WO2011066168A1 Potassium channel modulators
06/03/2011WO2011065402A1 Indole compound and pharmaceutical use thereof
06/03/2011WO2011064376A1 Imidazole derivatives as aldosterone synthase inhibitors
06/03/2011WO2011064328A1 Triazolopyridine derivatives
06/03/2011WO2011064250A1 Novel naphthyridine derivatives and the use thereof as kinase inhibitors
06/03/2011WO2011064189A1 Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate
06/03/2011WO2011064171A2 Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate and its purification for use thereof as pharmaceutical substance
06/03/2011WO2011064156A2 Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} carbamate and its purification for use thereof as pharmaceutical substance
06/03/2011WO2011063908A1 Triazolopyridines
06/03/2011WO2011063907A1 Substituted triazolopyridines
06/03/2011WO2011031764A3 Compounds and related methods of use
06/03/2011WO2011014795A3 Compounds and compositions as syk kinase inhibitors
06/03/2011CA2782024A1 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
06/03/2011CA2782012A1 Triazolopyridine derivatives
06/03/2011CA2781922A1 Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} carbamate and its purification for use thereof as pharmaceutical substance
06/03/2011CA2781915A1 Triazolopyridines
06/03/2011CA2781914A1 Substituted triazolopyridines
06/03/2011CA2781818A1 Novel naphthyridine derivatives and the use thereof as kinase inhibitors
06/03/2011CA2781808A1 Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate
06/03/2011CA2781799A1 Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate and its purification for use thereof as pharmaceutical substance
06/03/2011CA2781660A1 Indole compound and pharmaceutical use thereof
06/03/2011CA2781292A1 Novel spiropiperidine compounds
06/03/2011CA2778266A1 Potassium channel modulators
06/02/2011US20110130567 Steroselective synthesis of certain trifluoromethyl-substituted alcohols
06/02/2011US20110130566 Perylene tetracarboximide derivatives for photovoltaic devices
06/02/2011US20110130436 Caspase inhibitors and uses thereof
06/02/2011US20110130417 New azacyclic derivatives
06/02/2011US20110130414 Novel fused thiazolo and oxazolo pyrimidinones
06/02/2011US20110130411 Process for preparing methyl carbamate and its purification for use as pharmaceutically active compound
06/02/2011US20110130410 Process for preparing methyl methylcarbamate and its purification for use as pharmaceutically active compound
06/02/2011US20110130406 Pyrazolo-pyridines as tyrosine kinase inhibitors
06/02/2011US20110130404 Quinoxalinedione derivatives
06/02/2011US20110130403 Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
06/02/2011US20110130400 Trpv4 antagonists
06/02/2011US20110130384 Amide compound
06/02/2011US20110130381 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
06/02/2011US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group
06/02/2011US20110130305 Novel dyes and compositions, and processes for using same in analysis of protein aggregation and other applications
06/02/2011US20110129419 In vivo imaging agents
06/02/2011US20110127513 Novel nitrogen-containing heterocyclic compound and organic electronic device using the same
06/01/2011EP2327703A1 Ligand with a broad spectrum of pharmacological activity, a pharmaceutical composition, a medicinal agent and a method of treatment
06/01/2011EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy
06/01/2011EP2326650A2 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
06/01/2011EP2326645A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it
06/01/2011EP2326644A1 Urotensin ii receptor antagonists
06/01/2011EP2326641A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
06/01/2011EP2326636A2 Pyrazole carboxamide inhibitors of factor xa
06/01/2011EP2326622A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
06/01/2011EP2326178A2 Prolyl hydroxylase inhibitors
06/01/2011EP2326177A1 3- and 6-quinolines with n-attached heterocyclic cgrp receptor antagonists
06/01/2011EP2326176A1 Non-amidic linkers with branched termini as cgrp receptor antagonists
06/01/2011EP2099796B1 Aza-indolyl compounds and methods of use
06/01/2011EP1981854B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
06/01/2011DE102010042864A1 Substituierte Thioamide mit herbizider Wirkung Substituted thioamides with herbicidal activity
06/01/2011CN102083832A Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 Tachikynin receptor antagonists
06/01/2011CN102083831A Naphthyridininones as AURORA kinase inhibitors
06/01/2011CN102083830A Pyrido [3, 4-b] indoles and methods of use
06/01/2011CN102083829A Improved Raf inhibitors
06/01/2011CN102083828A Heterocyclic compounds and compositions as C-KIT and PDGFR kinase inhibitors
06/01/2011CN102083827A Thiazolidine compounds as orexin receptor antagonists
06/01/2011CN102083817A Compounds and compositions as ITPKB inhibitors
06/01/2011CN102083800A Heteroaryl compounds and uses thereof
06/01/2011CN102083790A Spiro(5.5)undecane derivatives
06/01/2011CN101537746B Heat resistance improver and reversible thermosensitive recording medium
06/01/2011CN101407489B 2-alkyl acrylate compounds and uses thereof
06/01/2011CN101353347B Preparation of risperidone
06/01/2011CN101171252B Tetracyclic azapyrazinoindolines as 5-HT2 ligands
05/2011
05/31/2011US7951958 Imidazole compounds for the treatment of neurodegenerative disorders
05/31/2011US7951948 Spirocyclic cyclohexane compounds
05/31/2011US7951820 Triazole compounds useful as protein kinase inhibitors
05/31/2011US7951815 Substituted 1,4,8-triazaspiro [4,5]decan-2-one compounds
05/31/2011US7951811 Pyrrolo[2,3-D]pyrimidine derivatives substituted with a cyclic amino group
05/31/2011US7951809 Inhibitors of p38